Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051025 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
A Phase 2 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00051025 is a Phase 2 study that has completed, run by Eisai. The registered enrollment target is 9 participants.
The verdict
NCT00051025, a Phase 2 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the safety and effectiveness of ONTAK in previously treated patients with NHL.
Interventions
- DRUG ONTAK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2000-05 |
| Est. Completion | 2006-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00051025
The ClinicalTrials.gov registry entry for NCT00051025 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ONTAK is the first listed.
NCT00051025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00051025 about?
NCT00051025 is a clinical study titled "Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)". The purpose of this study is to look at the safety and effectiveness of ONTAK in previously treated patients with NHL.
What is the current status of trial NCT00051025?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2000-05. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00051025?
The interventions under investigation include: ONTAK (DRUG).
Who is sponsoring clinical trial NCT00051025?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.